Ultrasound imaging in the diagnosis of large vessel vasculitis

Vasa - European Journal of Vascular Medicine

Volumn 46, Issue 4, 2017, Pages 241-253

  Czihal, Michael ^a   Lottspeich, Christian ^a   Hoffmann, Ulrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic periaortitis; Colour duplex sonography; Giant cell arteritis; Large vessel vasculitis; Takayasu arteritis; Ultrasound

Indexed keywords

CORTICOSTEROID; ECHO CONTRAST MEDIUM; SULFUR HEXAFLUORIDE; CONTRAST MEDIUM;

ANGIOGRAPHY; AORTIC ARCH SYNDROME; ARTERIAL WALL THICKNESS; B SCAN; BEHCET DISEASE; BLOOD FLOW VELOCITY; BUERGER DISEASE; CARDIAC IMAGING; CAROTIDYNIA; CHRONIC PERIAORTITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DUPLEX DOPPLER ULTRASONOGRAPHY; ECHOGRAPHY; FOLLOW UP; GIANT CELL ARTERITIS; HISTOLOGY; HUMAN; LARGE VESSEL VASCULITIS; MULTICENTER STUDY (TOPIC); NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR DISEASE; VASCULITIS; ARTERY; COLOR DOPPLER FLOWMETRY; EARLY DIAGNOSIS; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ARTERIES; CONTRAST MEDIA; EARLY DIAGNOSIS; GIANT CELL ARTERITIS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TAKAYASU ARTERITIS; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULITIS;

EID: 85024502849     PISSN: 03011526     EISSN: 16642872     Source Type: Journal    
DOI: 10.1024/0301-1526/a000625     Document Type: Review

References (96)

1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.
2. Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: State of the art. Best Pract Res Clin Rheumatol. 2016;30(4):688–706.
3. Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337(19):1336–42.
4. Roman MJ, Naqvi TZ, Gardin JM, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11(3):201–11.
5. Schäfer VS, Juche A, Ramiro S, et al. Cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology (Oxford). 2017. accepted for publication.
6. Aschwanden M, Daikeler T, Kesten F, et al. Temporal artery compression sign-a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med. 2013;34(1):47–50.
7. Schmidt WA. Technology Insight: the role of color and power Doppler ultrasonography in rheumatology. Nat Clin Pract Rheumatol. 2007;3(1):35–42.
8. Horng A, Reiser M, Clevert DA. Current developments in vascular ultrasound. Radiologe. 2009;49(11):998–1004.
9. Volpe A, Caramaschi P, Marchetta A, et al. B-flow ultrasound in a case of giant cell arteritis. Clin Rheumatol. 2007;26(11):1955–7.
10. Clevert DA, Rupp N, Reiser M, et al. Improved diagnosis of vascular dissection by ultrasound B-flow: a comparison with color-coded Doppler and power Doppler sonography. Eur Radiol. 2005;15(2):342–7.
11. Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33(1):33–59.
12. Staub D, Partovi S, Imfeld S, et al. Novel applications of contrast-enhanced ultrasound imaging in vascular medicine. Vasa. 2013;42(1):17–31.
13. Staub D. Atherosclerotic plaque neovascularization and inflammation - is there a link? Vasa. 2015;44(3):163–5.
14. Prieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol. 2015;27(1):53–62.
15. Czihal M, Zanker S, Rademacher A, et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol. 2012;41(3):231–6.
16. Schmidt WA, Kraft HE, Völker L, et al. Colour Doppler sonography to diagnose temporal arteritis. Lancet. 1995;345(8953):866.
17. Schmidt WA, Natusch A, Möller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20(3):309–18.
18. Pfadenhauer K, Weber H. Giant cell arteritis of the occipital arteries - a prospective color coded duplex sonography study in 78 patients. J Neurol. 2003 Jul;250(7):844–9.
19. Arida A, Kyprianou M, Kanakis M, et al. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010;11:44.
20. Schmidt WA, Krause A, Schicke B, et al. Do temporal artery duplex ultrasound findings correlate with ophthalmic com- plications in giant cell arteritis? Rheumatology (Oxford). 2009;48(4):383–5.
21. De Miguel E, Castillo C, Rodríguez A, et al. 13. Learning and reliability of colour Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S53–8.
22. Chrysidis S, Fredberg U, Møller Døhn U, et al. A Structured and Extensive Training Program on Vascular Ultrasound, Results in an Excellent Agreement Between Ultrasound and Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis. Arthritis Rheumatol. 2015; 67 (suppl 10).
23. Aschwanden M, Imfeld S, Staub D, et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol. 2015;33(2 Suppl 89):113–5.
24. Chrysidis S, Duftner C, Dejaco C, et al. Ultrasound Definitions for Cranial and Large Vessel Giant Cell Arteritis: Results of a Reliability Exercise on Images and Videos of the Omeract Ultrasound Large Vessel Vasculitis Task Force [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10).
25. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58(8):2574–8.
26. Arida A, Kyprianou M, Kanakis M, et al. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010;11:44.
27. Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 2006;8(4):R116.
28. Diamantopoulos AP, Haugeberg G, Hetland H, et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res (Hoboken). 2014;66(1):113–9.
29. De Miguel E, Roxo A, Castillo C, et al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol. 2012;30(1 Suppl 70):34–8.
30. Hauenstein C, Reinhard M, Geiger J, et al. Effects of early corti-costeroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford). 2012;51(11):1999–2003.
31. Pérez López J, Solans Laqué R, Bosch Gil JA, et al. Colour-du-plex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl 52):77–82.
32. Diamantopoulos AP, Myklebust G. Long-term inflammation in the temporal artery of a giant cell arteritis patient as detected by ultrasound. Ther Adv Musculoskelet Dis. 2014;6(3):102–3.
33. Restuccia G, Cavazza A, Boiardi L, et al. Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis. Arthritis Rheum. 2012;64(2):549–56.
34. Muratore F, Boiardi L, Restuccia G, et al. Comparison between colour duplex sonography findings and different histological patterns of temporal artery. Rheumatology (Oxford). 2013;52(12):2268–74.
35. Germanò G, Muratore F, Cimino L, et al. Is colour duplex sonog-raphy-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology (Ox-ford). 2015;54(3):400–4.
36. Patil P, Williams M, Maw WW, et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol. 2015;33(2 Suppl 89):103–6.
37. Diamantopoulos AP, Haugeberg G, Lindland A, et al. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford). 2016;55(1):66–70.
38. Alberts MS, Mosen DM. Diagnosing temporal arteritis: duplex vs. biopsy. QJM. 2007;100(12):785–9.
39. Schmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47(1):96–101.
40. Ghinoi A, Pipitone N, Nicolini A, et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford). 2012;51(4):730–4.
41. Sturm A, Dechant C, Proft F, et al. Gender differences in giant cell arteritis: a case-control study. Clin Exp Rheumatol. 2016;34(3 Suppl 97):70–2.
42. Czihal M, Tatò F, Förster S, et al. Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. Clin Exp Rheumatol. 2010;28(4):549–52.
43. Czihal M, Piller A, Schroettle A, et al. Impact of cranial and axil-lary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis. J Vasc Surg. 2015;61(5):1285–91.
44. Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47(9):1406–8.
45. Czihal M, Piller A, Schroettle A, et al. Outcome of giant cell arteritis of the arm arteries managed with medical treatment alone: cross-sectional follow-up study. Rheumatology (Oxford). 2013;52(2):282–6.
46. Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69(7):1356–9.
47. Gonzalez-Juanatey C, Lopez-Diaz MJ, Martin J, et al. Atherosclerosis in patients with biopsy-proven giant cell arteritis. Arthritis Rheum. 2007;57(8):1481–6.
48. Pfadenhauer K, Esser M, Berger K. Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica--an ultrasonographic case-control study. J Rheumatol. 2005;32(12):2356–60.
49. Pfadenhauer K, Weinerth J, Hrdina C. Vertebral arteries: a target for FDG-PET imaging in giant cell arteritis? Clinical, ultrasonographic and PET study in 46 patients. Nuklearmedizin. 2011;50(1):28–32.
50. García-García J, Ayo-Martín Ó, Argandoña-Palacios L, et al. Vertebral artery halo sign in patients with stroke: a key clue for the prompt diagnosis of giant cell arteritis. Stroke. 2011;42(11):3287–90.
51. Palmers PJ, Ameloot K, De Wever W, et al. Eur Heart J Cardiovasc Imaging. 2013;14(5):434. An echocardiographic finding leading to the diagnosis of giant cell arteritis.
52. Margos PN, Moyssakis IE, Tzioufas AG, et al. Impaired elastic properties of ascending aorta in patients with giant cell arteritis. Ann Rheum Dis. 2005;64(2):253–6.
53. Agard C, Hamidou MA, Said L, et al. Screening of abdominal aortic involvement using Doppler sonography in active giant cell (temporal) arteritis at the time of diagnosis. A prospective study of 30 patients. Rev Med Interne. 2007;28(6):363–70.
54. Tatò F, Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg. 2006;44(1):176–82.
55. Czihal M, Tatò F, Rademacher A, et al. Involvement of the femoropopliteal arteries in giant cell arteritis: clinical and color duplex sonography. J Rheumatol. 2012;39(2):314–21.
56. Tatò F, Hoffmann U. Giant cell arteritis: a systemic vascular disease. Vasc Med. 2008;13(2):127–40.
57. Brodmann M, Lipp RW, Passath A, et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43(2):241–2.
58. Förster S, Tato F, Weiss M, et al. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. Vasa. 2011;40(3):219–27.
59. Luqmani R, Lee E, Singh S, et al. The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-ef-fectiveness study. Health Technol Assess. 2016;20(90):1–238.
60. Czihal M, Hoffmann U. Vasculitis. In: Dieter R, et al. Critical Limb Ischemia – Acute and Chronic. Springer International Publishing 2017.
61. Maeda H, Handa N, Matsumoto M, et al. Carotid lesions detected by B-mode ultrasonography in Takayasu’s arteritis: “macaroni sign” as an indicator of the disease. Ultrasound Med Biol. 1991;17(7):695–701.
62. Raninen RO, Kupari MM, Pamilo MS, et al. Arterial wall thickness measurements by B mode ultrasonography in patients with Takayasu’s arteritis. Ann Rheum Dis. 1996;55(7):461–5.
63. Sun Y, Yip PK, Jeng JS, et al. Ultrasonographic study and long-term follow-up of Takayasu’s arteritis. Stroke. 1996;27(12):2178–82.
64. Lefebvre C, Rance A, Paul JF, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu’s arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30(1):25–32.
65. Nam SJ, Kim EK, et al. Incidentally diagnosed Takayasu arteritis on thyroid ultrasonography showing prominent collateral vessels of thyroidal arteries and common carotid artery occlusion. Ultrasonography. 2014;33(3):222–5.
66. Li J, Shi D, Wei Y, et al. Blood flow in the internal carotid artery with common carotid artery-occluding lesions in Takayasu arteritis. J Ultrasound Med. 2010;29(11):1547–53.
67. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis. 2006;65(9):1202–7.
68. Ringleb PA, Strittmatter EI, Loewer M, et al. Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford). 2005;44(8):1012–5.
69. Bezerra Lira-Filho E, Campos O, Lazaro Andrade J, et al. Thoracic aorta evaluation in patients with Takayasu’s arteritis by transesophageal echocardiography. J Am Soc Echocardiogr. 2006;19(6):829–34.
70. Schmidt WA, Nerenheim A, Seipelt E, et al. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford). 2002;41(5):496–502.
71. Zeller T, Bonvini RF, Sixt S, et al. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Cardiovasc Interv. 2008;71(7):995–9.
72. Soto ME, Espinola-Zavaleta N, Ramirez-Quito O, et al. Echocardiographic follow-up of patients with Takayasu’s arteritis: five-year survival. Echocardiography. 2006;23(5):353–60.
73. Fan W, Zhu J, Li J, et al. Ultrasound morphological changes in the carotid wall of Takayasu’s arteritis: monitor of disease progression. Int Angiol. 2016;35(6):586–92.
74. Seth S, Goyal NK, Jagia P, et al. Carotid intima-medial thickness as a marker of disease activity in Takayasu’s arteritis. Int J Cardiol. 2006;108(3):385–90.
75. Sinha D, Mondal S, Nag A, et al. Development of a colour Doppler ultrasound scoring system in patients of Takayasu’s arteritis and its correlation with clinical activity score (ITAS 2010). Rheumatology (Oxford). 2013;52(12):2196–202.
76. Schinkel AF, van den Oord SC, van der Steen AF, et al. Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging. 2014;15(5):541–6.
77. Germanò G, Macchioni P, Possemato N, et al. Contrast-Enhanced Ultrasound of the Carotid Artery in Patients With Large Vessel Vasculitis: Correlation With Positron Emission Tomography Findings. Arthritis Care Res (Hoboken). 2017;69(1):143–9.
78. Giordana P, Baqué-Juston MC, Jeandel PY, et al. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: first evidence of application in diagnosis and monitoring of response to treatment. Circulation. 2011;124(2):245–7.
79. Herlin B, Baud JM, Chadenat ML, et al. Contrast-enhanced ultrasonography in Takayasu arteritis: watching and moni- toring the arterial inflammation. BMJ Case Rep. 2015 Oct 9;2015.
80. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol. 2011;23(1):1–6.
81. Palmisano A, Urban ML, Corradi D, et al. Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? Rheumatology (Oxford). 2015;54(11):2004–9.
82. Caiafa RO, Vinuesa AS, Izquierdo RS, et al. Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiograph-ics. 2013;33(2):535–52.
83. Treglia G, Mattoli MV, Bertagna F, et al. Emerging role of Fluo-rine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review. Rheumatol Int. 2013;33(3):549–55.
84. Sanders RC, Duffy T, Mcloughlin MG, et al. Sonography in the diagnosis of retroperitoneal fibrosis. J Urol. 1977;118(6):944–6.
85. Feinstein RS, Gatewood OM, Goldman SM, et al. Computerized tomography in the diagnosis of retroperitoneal fibrosis. J Urol. 1981;126(2):255–9.
86. Kamper L, Brandt AS, Ekamp H, et al. The potential role of modern US in the follow-up of patients with retroperitoneal fibrosis. Diagn Interv Radiol. 2014;20(1):3–8.
87. Partovi S, Imfeld S, Aschwanden M, et al. The Use of Contrast-enhanced Ultrasound (CEUS) in Chronic Periaortitis. Ultraschall Med. 2012 Aug 7. [Epub ahead of print].
88. Steubl D, Thürmel K, Moog P, et al. Comparison of fluorine-18-deoxyglucose positron emission tomography/computed tomography and contrast-enhanced ultrasound in a patient with chronic periaortitis. Vasa. 2013;42(5):370–4.
89. Tardy J, Pariente J, Nasr N, et al. Carotidynia: a new case for an old controversy. Eur J Neurol. 2007;14(6):704–5.
90. Arning C. Ultrasonography of carotidynia. AJNR Am J Neuroradiol. 2005 Jan;26(1):201–2.
91. Kosaka N, Sagoh T, Uematsu H, et al. Imaging by multiple modalities of patients with a carotidynia syndrome. Eur Radiol. 2007;17(9):2430–3.
92. Hafner F, Hackl G, Haas E, et al. Idiopathic carotidynia. Vasa. 2014;43(4):287–92.
93. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet’s disease: an update. Curr Opin Rheumatol. 2011;23(1):24–31.
94. Klein-Weigel PF, Richter JG. Thromboangiitis obliterans (Buerger’s disease). Vasa. 2014;43(5):337–46.
95. Fujii Y, Soga J, Hidaka T, et al. Color doppler flows of corkscrew collaterals in Thromboangiitis obliterans (Buerger’s disease) using color duplex ultrasonography. J Am Coll Cardiol. 2011;57 (25):2539.
96. Tranquart F, Mercier L, Frinking P, et al. Perfusion quantifica-tion in contrast-enhanced ultrasound (CEUS)--ready for research projects and routine clinical use. Ultraschall Med. 2012;33 Suppl 1:31–8.